Skip to main content

Johnson & Johnson (JNJ) Stock Price & Market Analysis

JNJ · NYSE · Drug Manufacturers - General

Market closedLatest available session print

$270.47

▲ +$3.33(+1.25%)4:00 PM ET - vs previous close

Quote as of Nov 20, 2026, 4:00 PM EST

Regular-session close · Nov 20, 2026, 4:00 PM EST.

Last session33%
$269.47L Nov 20 '26$272.48H Nov 20 '26
52-week range78%
$199.91$290.25H Nov 16 '26
Long-term rangesAvailable history
Available history(2000-11-22)93%
$20.47L Mar 27 '01$290.25H Nov 16 '26

Historical range: 2000-11-22–2026-11-20. Earlier trading may not be included.

Loading price chart…

Data dates

PriceAt closeLast traded

FundamentalsLast checked

AnalystLast checked

NewsLatest item

What matters next

Next important events

  1. Jan 26, 2027Next earnings (est.) · After market closeEstimated · After market close · Last verified 2026-11-21

Countdown

65 days out

Reported fundamentals

JNJ financial overview

Annual revenue

USD 94.19B

Sales for the fiscal year ended Dec 28, 2025. This is not trailing twelve-month revenue.

Revenue change

+6.0%

Change versus the fiscal year ended Dec 29, 2024.

Net profit margin

28.5%

Net income divided by revenue for the fiscal year ended Dec 28, 2025. This is not the trailing margin.

These reported results describe the business’s recent scale and profitability. Compare cash generation and valuation before forming an investment view; historical growth is not a forecast.

Company · ProfileAbout Johnson & Johnson (JNJ)Sector, leadership, and how Johnson & Johnson earns its revenue.

Johnson & Johnson

NYSE · JNJ · US

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Company overview as of Nov 22, 2026.

Sector
Healthcare
Industry
Drug Manufacturers - General
Headquarters
New Brunswick, NJ, United States
Country
US
Founded
1944
Employees
141,700
CEO
Mr. Joaquin Duato
Exchange
NYSE
Business model & operating resultsExplore business exposure, reported operating measures and the figures behind growth and profitability claims.

Company website ↗

Narrative versus numbers

Demand is expanding

Supporting observation: 5.9%

Year-over-year growth in the latest quarter. This differs from the fiscal-year revenue change shown above. · Source timestamp: Sep 27, 2026

Growth produces accounting profit

Supporting observation: 16.2%

Net margin; the source did not supply a reporting period. Do not compare this reading with the quarterly or fiscal-year figures above. A positive margin does not establish cash generation. · Source timestamp: Nov 22, 2026, 3:12 PM EST

The business generates cash after investment

Supporting observation: USD 6.36B

Latest free cash flow from the statement feed. It is not a forecast and may cover a different period from the fiscal-year figures above. · Source timestamp: Sep 27, 2026

These are explicit tests of individual claims, not an overall bull/bear rating. Demand growth can coexist with valuation, concentration and financing risk.

Operating measures

Revenue
$25.40Bquarter ended Sep 27, 2026
Gross margin
68.1%quarter ended Sep 27, 2026
EPS
$0.09quarter ended Sep 27, 2026
Capital expenditure
$1.36Bquarter ended Sep 27, 2026
Free cash flow
$6.36Bquarter ended Sep 27, 2026
Free cash flow margin
25.0%quarter ended Sep 27, 2026
Operating cash / net income
36.76×quarter ended Sep 27, 2026
Revenue growth year over year
5.9%quarter ended Sep 27, 2026
Competitors & comparisonsCompare industry peers, reporting periods and related funds. Business mix and valuation bases may differ.
Valuation & fund comparisonsExplore dated peer valuations, growth comparisons and related funds.

Governance & sustainability

Find proxy statements and annual reports

Data sources: Financial Modeling Prep · Finnhub · SEC Companyfacts · Yahoo Finance

Market data is for information only and is not trading advice. Prices and fundamentals may be delayed, reflect an earlier observation, be incomplete, or be revised. Read the data methodology or the full disclaimer.
Research tools
Market closed

Regular hours: 9:30 AM–4:00 PM America/New_York

Next open: 2026-11-23 · 9:30 AM America/New_York

Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.